Sepsis-induced cardiac dysfunction, lung edema, and declined anti-inflammatory responses can be reversed by genetic ablation or pharmacological inhibition of sphingomyelin phosphodiesterase (SMPD1) and Sphk in septic rodents (118, 124, 125, 126). The gene discussed is SPHK1; the disease is Sepsis.